MANAGEMENT OF ADVERSE REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

被引：65
作者：
JUNG, AC
PAAUW, DS
机构：
[1] Department of Medicine, University of Washington, Seattle, WA
[2] Department of Medicine, Div. of General Internal Medicine, University of Washington, Seattle
来源：
ARCHIVES OF INTERNAL MEDICINE | 1994年 / 154卷 / 21期
关键词：
D O I：
10.1001/archinte.154.21.2402
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Trimethoprim-sulfamethoxazole is an important medication for the treatment and prevention of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Use of this medication has been limited by the high frequency of adverse reactions that occur in patients with human immunodeficiency virus disease. This article reviews the incidence and spectrum of adverse reactions and options for continuing therapy with trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients who have adverse reactions.
引用
收藏
页码：2402 / 2406
页数：5
相关论文
共 53 条
[1]  
AGUILAR X, 1991, AIDS, V5, P777, DOI 10.1097/00002030-199106000-00025
[2]   SEVERE HYPERSENSITIVITY REACTION UPON RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN A PATIENT WITH AIDS [J].
ARNOLD, PA ;
GUGLIELMO, BJ ;
HOLLANDER, H .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (01) :43-45
[3]  
BORUCKI MJ, 1988, ANN INTERN MED, V148, P77
[4]   A CONTROLLED TRIAL OF EARLY ADJUNCTIVE TREATMENT WITH CORTICOSTEROIDS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BOZZETTE, SA ;
SATTLER, FR ;
CHIU, J ;
WU, AW ;
GLUCKSTEIN, D ;
KEMPER, C ;
BARTOK, A ;
NIOSI, J ;
ABRAMSON, I ;
COFFMAN, J ;
HUGHLETT, C ;
LOYA, R ;
CASSENS, B ;
AKIL, B ;
MENG, TC ;
BOYLEN, CT ;
NIELSEN, D ;
RICHMAN, DD ;
TILLES, JG ;
LEEDOM, J ;
MCCUTCHAN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) :1451-1457
[5]   CLINICAL AND LABORATORY MARKERS OF HYPERSENSITIVITY TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN PATIENTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA AND AIDS [J].
CARR, A ;
SWANSON, C ;
PENNY, R ;
COOPER, DA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :180-185
[6]   EFFICACY AND SAFETY OF RECHALLENGE WITH LOW-DOSE TRIMETHOPRIM SULFAMETHOXAZOLE IN PREVIOUSLY HYPERSENSITIVE HIV-INFECTED PATIENTS [J].
CARR, A ;
PENNY, R ;
COOPER, DA .
AIDS, 1993, 7 (01) :65-71
[7]   LOW-DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS [J].
CARR, A ;
TINDALL, B ;
BREW, BJ ;
MARRIOTT, DJ ;
HARKNESS, JL ;
PENNY, R ;
COOPER, DA .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) :106-111
[8]   THE ACQUIRED IMMUNODEFICIENCY SYNDROME AND A TRIMETHOPRIM-SULFAMETHOXAZOLE ADVERSE REACTION [J].
COHN, DL ;
PENLEY, KA ;
JUDSON, FN ;
KIRKPATRICK, CH ;
HORSBURGH, CR ;
DAVIS, KC .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (02) :311-311
[9]   CUTANEOUS REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN AFRICAN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
COLEBUNDERS, R ;
IZALEY, L ;
BILA, K ;
KABUMPANGI, K ;
MELAMEKA, N ;
NYST, M ;
FRANCIS, H ;
CURRAN, JW ;
RYDER, R ;
PIOT, P .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) :599-600
[10]   CUTANEOUS REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HAITIANS [J].
DEHOVITZ, JA ;
JOHNSON, WD ;
PAPE, JW .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) :479-480
123456